121 related articles for article (PubMed ID: 33934966)
1. Can dynamic contrast enhanced MRI predict gleason score in prostate cancer? a systematic review and meta analysis.
Meyer HJ; Wienke A; Surov A
Urol Oncol; 2021 Nov; 39(11):784.e17-784.e25. PubMed ID: 33934966
[TBL] [Abstract][Full Text] [Related]
2. Discrimination between clinical significant and insignificant prostate cancer with apparent diffusion coefficient - a systematic review and meta analysis.
Meyer HJ; Wienke A; Surov A
BMC Cancer; 2020 May; 20(1):482. PubMed ID: 32460795
[TBL] [Abstract][Full Text] [Related]
3. Application evaluation of DCE-MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer.
Ma XZ; Lv K; Sheng JL; Yu YX; Pang PP; Xu MS; Wang SW
Oncol Lett; 2019 Mar; 17(3):3077-3084. PubMed ID: 30867737
[TBL] [Abstract][Full Text] [Related]
4. Quantitative diffusion-weighted imaging and dynamic contrast-enhanced MR imaging for assessment of tumor aggressiveness in prostate cancer at 3T.
Fukunaga T; Tamada T; Kanomata N; Takeuchi M; Ueda Y; Miyaji Y; Kido A; Yamamoto A; Sone T
Magn Reson Imaging; 2021 Nov; 83():152-159. PubMed ID: 34454006
[TBL] [Abstract][Full Text] [Related]
5. Differential diagnosis of prostate cancer and noncancerous tissue in the peripheral zone and central gland using the quantitative parameters of DCE-MRI: A meta-analysis.
Gao P; Shi C; Zhao L; Zhou Q; Luo L
Medicine (Baltimore); 2016 Dec; 95(52):e5715. PubMed ID: 28033274
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
[TBL] [Abstract][Full Text] [Related]
7. T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results.
Nketiah G; Elschot M; Kim E; Teruel JR; Scheenen TW; Bathen TF; Selnæs KM
Eur Radiol; 2017 Jul; 27(7):3050-3059. PubMed ID: 27975146
[TBL] [Abstract][Full Text] [Related]
8. The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer.
Cindil E; Oner Y; Sendur HN; Ozdemir H; Gazel E; Tunc L; Cerit MN
Can Assoc Radiol J; 2019 Nov; 70(4):441-451. PubMed ID: 31561925
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Dispersion MRI for Improved Prostate Cancer Diagnosis in a Multicenter Study.
Turco S; Lavini C; Heijmink S; Barentsz J; Wijkstra H; Mischi M
AJR Am J Roentgenol; 2018 Nov; 211(5):W242-W251. PubMed ID: 30346837
[TBL] [Abstract][Full Text] [Related]
10. Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up.
Hamoen EHJ; Hoeks CMA; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Bokhorst LP; Witjes JA; Rovers MM; Hulsbergen-van de Kaa CA; Barentsz JO
Eur Urol Focus; 2019 May; 5(3):407-415. PubMed ID: 29331622
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.
Zawaideh JP; Sala E; Shaida N; Koo B; Warren AY; Carmisciano L; Saeb-Parsy K; Gnanapragasam VJ; Kastner C; Barrett T
Eur Radiol; 2020 Jul; 30(7):4039-4049. PubMed ID: 32166495
[TBL] [Abstract][Full Text] [Related]
12. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer.
Bleker J; Kwee TC; Dierckx RAJO; de Jong IJ; Huisman H; Yakar D
Eur Radiol; 2020 Mar; 30(3):1313-1324. PubMed ID: 31776744
[TBL] [Abstract][Full Text] [Related]
14. Correlations between Apparent Diffusion Coefficient and Gleason Score in Prostate Cancer: A Systematic Review.
Surov A; Meyer HJ; Wienke A
Eur Urol Oncol; 2020 Aug; 3(4):489-497. PubMed ID: 31412009
[TBL] [Abstract][Full Text] [Related]
15. Quantitative parameters in dynamic contrast-enhanced magnetic resonance imaging for the detection and characterization of prostate cancer.
Wei C; Jin B; Szewczyk-Bieda M; Gandy S; Lang S; Zhang Y; Huang Z; Nabi G
Oncotarget; 2018 Mar; 9(22):15997-16007. PubMed ID: 29662622
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
17. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
[TBL] [Abstract][Full Text] [Related]
18. Correlation of quantitative diffusion-weighted and dynamic contrast-enhanced MRI parameters with prognostic factors in prostate cancer.
Chung MP; Margolis D; Mesko S; Wang J; Kupelian P; Kamrava M
J Med Imaging Radiat Oncol; 2014 Oct; 58(5):588-94. PubMed ID: 25196228
[TBL] [Abstract][Full Text] [Related]
19. MpMRI of the prostate: is there a role for semi-quantitative analysis of DCE-MRI and late gadolinium enhancement in the characterisation of prostate cancer?
Cristel G; Esposito A; Briganti A; Damascelli A; Brembilla G; Freschi M; Ambrosi A; Montorsi F; Del Maschio A; De Cobelli F
Clin Radiol; 2019 Apr; 74(4):259-267. PubMed ID: 30739715
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study.
Ullrich T; Arsov C; Quentin M; Mones F; Westphalen AC; Mally D; Hiester A; Albers P; Antoch G; Schimmöller L
Eur Radiol; 2020 Nov; 30(11):6042-6051. PubMed ID: 32591887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]